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ABSTRACT
Objectives: Akar kuning (Arcangelisia flava) was known to have various pharmacological activities including as antibacterial. Several Gram-positive 
and Gram-negative bacteria show response to akar kuning secondary metabolites, although the type of metabolites that inhibit the growth of each 
type of bacteria not yet known. This study aims to obtain the prediction of metabolites from akar kuning with the greatest antibacterial potential 
against various types of antibacterial receptors.
Methods: Molecular docking was performed using Autodock Vina 1.1.2 on several secondary metabolites of akar kuning against active site of several 
antibacterial receptors that were known for many antibiotics including as cell wall, protein, nucleic acid synthesis inhibitors, and antimetabolites. The 
main parameter used was the free energy of binding as affinity marker.
Results: The docking results show that among 11 metabolites studied, 6-hydroxyfibraurin, berberine, and fibleucin provided the lowest free energy of 
binding between 11 antibacterial receptors compared with natural substrates or inhibitors from each receptor. Interesting results show by berberine 
as inhibitor of protein synthesis with possibility of allosteric site discovery. Berberine also shows more than 75% similarity with natural substrate of 
cell wall inhibition receptor, indicating possible similar type of interaction.
Conclusion: Overall, it seems that for the selected secondary metabolites of akar kuning, the main mechanism of action was the inhibition of protein 
and cell wall synthesis, which was shown by berberine.
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INTRODUCTION
The discovery of new antimicrobial compounds is undeniably still 
one of the interesting topics to be studied, where the need for new 
antimicrobials to combat microbial resistance is still constrained 
by the availability of antimicrobials that are safe to use [1,2]. Our 
backwardness from the process of microbial resistance several times 
puts us in a dangerous position with the spread of infection due to 
harmful microbes, as has happened in the case of avian and swine 
influenza that once threatened humanity in the early 2000s [3,4]. 
Lucky for us, nature always gives clues on how to win the fight with 
these microbial infections. Various compounds obtained from natural 
products, both direct and modified extraction, have been proven to 
overcome the problem of microbial resistance [5,6].
Although there is a tendency to shift the approach to the discovery 
of new antimicrobial compounds with a rational approach using 
computer-aided drug design, the discovery of compounds derived 
from natural products remains an interesting field to do considering 
the large selection of medicinal plants that have not been studied 
[7,8]. While the rational approach provides ideas for optimizing the 
antimicrobial activity of these compounds, tracing active compounds 
from natural products provide a new dimension for starting 
compounds that can be optimized by rational approaches [9,10]. The 
combination of both approaches provides comprehensive information 
for researchers to be able to develop active metabolite derivatives 
from medicinal plants [11]. However, both approaches share similar 
problems where not all medicinal plants that have antimicrobial 
activity are produced by a single compound, making it difficult to 
analyze them in silico because rational approaches require interaction 
between single ligand receptors [12]. In silico analysis of secondary 
metabolites one by one is a way that can be done to prove the efficacy 
of each metabolite [13].
One of the plants known to be efficacious as an antimicrobial but 
not yet known as the secondary metabolite responsible for this 
activity is the akar kuning (Arcangelisia flava). Several studies have 
shown that the ethanol extract of akar kuning stems has excellent 
antimicrobial activity against various microbes both bacteria and 
fungi [14,15]. The antimicrobial spectrum of akar kuning extracts 
is even quite extensive including some Gram-positive and Gram-
negative bacteria [16,17]. This activity is mainly associated with 
the ability of secondary root metabolites as antimicrobials through 
various pathways including inhibition of cell wall, protein, nucleic 
acid synthesis, and antimetabolites [18-20]. Still, the type of 
secondary metabolite that has the most potent activity and the 
mechanism of antimicrobial activity that occurs from akar kuning 
is still unknown.
This study aims to find secondary metabolites of akar kuning with 
the highest potential as antimicrobials, as well as determining the 
types of antimicrobial mechanisms that occur in these metabolites. 
The study was conducted in silico by molecular docking method to 
determine secondary metabolites with the highest affinity for several 
known antimicrobial receptors. Metabolites with the highest affinity 
then compared with comparative compounds to determine the level of 
similarity of amino acid interactions that occur, indicating this potential 
as an antimicrobial compound.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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METHODS
Ligands preparation
The ligand used was 11 known secondary metabolites from akar 
kuning as shown in Fig. 1 consisting of 2-dehydroaxyarcangelisinol (1), 
6-hydroxyarcangelisin (2), 6-hydroxyfibleucin (3), 6-hydroxyfibraurin (4), 
berberine (5), columbamine (6), fibleucin (7), fibraurin (8), jatrorrhizine 
(9), palmatine (10), and tinophyllol (11) [11,15]. The two-dimension 
structure of ligands was sketched using Gauss View 3.08 Software from 
Gaussian, Inc. All structures were geometry optimized by Hartree–Fock 
method basis set 3-21G with Gaussian 03 W software from Gaussian, 
Inc. Ideal conformation of following compounds has been provided by 
performing geometry optimization, which approaching conformation 
of these compounds in nature [9]. Optimized structures format changed 
from.log to.pdb using Open Babel 2.4.1 software [21]. The using of Open 
Babel software makes it very easy to transform ligands from one format to 
another [22]. Docking program used in this study was Autodock Vina 1.1.2 
from The Scripps Research Institute [23]. All ligands then are given the 
charge and set torque using software AutoDockTools 1.5.6 [24].
Receptors preparation
The molecular structure of all receptors was obtained from website 
of Protein Data Bank (PDB) http://www.rscb.org. The receptors were 
downloaded in.pdb format and then removed the unused portion, added 
the non-polar hydrogen group, given the charge, and set the grid box size 
and coordinate using software AutoDockTools 1.5.6 [25]. 11 receptors 
were used in the docking process and were divided into four groups 
consisting of cell wall, protein, and nucleic acid synthesis inhibitors, as 
well as antimetabolites [18-20]. The used structure of each receptor is 
the active site which is known as antimicrobial as cocrystal ligands.
Molecular docking
Molecular docking is done using software AutoDock Vina 1.1.2 from 
The Scripps Research Institute. The main parameter used in docking 
process was the free energy of binding (∆G) as affinity marker and 
amino acid’s residues as similarity marker [7,26]. The more negative ΔG 
shows the higher ligand affinity for the active side of the receptor [27]. 
Test ligand with the highest affinity was compared with redocking 
result of cocrystal ligand to determine the potency of test ligand as 
each receptors inhibitor by comparing the value of ΔG [28]. The amino 
acid’s residues of selected test ligand for each receptor then compared 
with amino acid’s residues of cocrystal ligand to assess the similarity of 
interaction between test and cocrystal ligand. The more similar amino 
acid’s residues indicate a higher probability that the test ligand will 
have similar activity with the cocrystal ligand [9].
Fig. 1: Structure of known secondary metabolites from akar kuning subjected for docking studies against antibacterial target proteins
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RESULTS AND DISCUSSION
Docking results were performed on the entire surface of each receptor with 
energy range, exhaustiveness, and number of modes parameters score 3, 
8, and 9, respectively. This number is default parameter for Autodock Vina 
1.1.2 for molecular docking purpose. Higher parameter will increase the 
accuracy of docking results [22]. The docking results data of all test ligands 
to all receptors were compared each other as shown in Table 1.
The first interesting thing to note is that all ligands give a negative ΔG value 
to all receptors, in other words, all ligands have an affinity for the active 
side of each receptor. The interaction that occurs between all ligands of 
each receptor will take place spontaneously, which is not always the case 
[27,29]. The first conclusion that can be drawn is that all test ligands used 
have the potential to interact with antimicrobial receptors, which means 
that they have the potential to be developed as antimicrobial compounds. 
However, not all ligands have a very negative ΔG value; hence, comparison 
with cocrystal ligands must be done to assess the real affinity of each test 
ligand [30]. As shown in Table 1, there are only three test ligands at eight 
receptors which show a more negative ΔG value than cocrystal ligand, 
where four of them are shown by berberine, an isoquinoline derivative 
alkaloid found in akar kuning and several other medicinal plants. At first 
glance, ligands that show the highest affinity compared to comparative 
ligands are berberine at protein synthesis receptors (PDB ID 4WYC) 
which shows a difference of ΔG of 2.7 kcal/mol. However, aspects that 
must be considered in molecular docking not only affinity, but also the 
similarity of amino acid residues [31].
Amino acid residues are another important parameter that must be 
considered, especially because of the high degree of uncertainty in 
molecular docking [24]. No matter, how large the ΔG difference between 
the test and comparative ligand docking results, if the amino acids that 
interact with the test ligand differ greatly from the comparative ligand, it 
is likely that the interaction will also be different [32]. Hence, it is wise to 
consider how the degree of similarity between amino acid residues from 
test ligands and comparative ligands to determine ligands with the highest 
affinity [33]. A comparison between amino acid residues from docking 
results of test and cocrystal ligand for each receptor is shown in Table 2.
In fact, the amino acid residue shown by berberine at the 4WYC 
receptor is completely different from that shown by cocrystal ligands, 
as shown in Fig. 2. These results imply that most likely the interaction 
between berberine and 4WYC receptors will be different from 
comparative ligands. However, different types of interactions do not 
mean that berberine does not have antimicrobial activity as an inhibitor 
of protein synthesis. Recent studies even shown that berberine can 
inhibit protein synthesis in microbes in vitro [34,35]. The different 
types of interactions found actually show that berberine is able to bind 
to the active site which is different from that shown by cocrystal ligand, 
perhaps even as an allosteric site. Interestingly, this also occurs in other 
protein synthesis inhibitors receptor (PDB ID 1HNJ) where none of 
the berberine amino acid residues are similar to comparative ligands. 
This certainly provides an advantage because the discovery of the 
allosteric site of the antimicrobial receptor can overcome the problem 
of antimicrobial resistance in microbes [6].
Another interesting feature is shown by berberine against cell wall 
synthesis receptor inhibitors (PDB ID 2ZDQ, a D-Alanine:D-Alanine 
Ligase enzyme), where three of the four amino acid residues in the 
cocrystal ligand also interact with berberine. This shows that berberine 
interactions are almost similar to those given by the natural substrate 
of the 2ZDQ receptor, in this case adenosine triphosphate (ATP) [18]. 
Visual observations as shown in Fig. 3 confirm that the position of 
berberine bonds is identical to the structure of adenosine in ATP so 
that parts with similar bonding positions are not functional elements of 
ATP phosphate groups. This assertion is important because the binding 
portion of ATP is an adenosine group so that if the interaction occurs in 
the phosphate group, then the possibility of the interaction occurring 
will not be the similar [36]. Similar interactions show that berberine 
can bind to receptors and become a competitive inhibitor of ATP. This 
is very beneficial because the 2ZDQ receptor is a ligase enzyme that 
requires ATP as a phosphate source [37]. Berberines that do not have a 
phosphate group and can compete with ATP to bind to the active side of 
the receptor can cause the microbial cell wall catalysis process to stop 
and eventually kill the microbes [38,39].
CONCLUSION
This study was successfully found the secondary metabolites of akar 
kuning with the highest potential as antimicrobials with berberine 
show affinity as inhibitors of protein and cell wall synthesis. Another 
valuable information that is obtained is the possibility of an allosteric 
site of the protein synthesis receptor, as demonstrated by berberine 
with very high affinity. Further, exploration of the allosteric site can 
be used to find antimicrobial compounds with higher activity as 
protein synthesis inhibitors, both from berberine derivatives and 
other compounds. Thus, with the introduction of metabolites with the 
highest antimicrobial activity, the use of akar kuning as antimicrobials 
can be optimized by extracting berberine as much as possible with the 
appropriate method.
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Table 1: Docking results from metabolites of akar kuning toward antimicrobial receptors
Receptor Validation ΔG of ligand (kcal/mol)
Type of receptors PDB ID ΔG (kcal/mol) 1 2 3 4 5 6 7 8 9 10 11
Inhibition of cell wall synthesis 1UAG −9.1 −8.6 −8.4 −8.1 −8.5 −7.9 −7.9 −7.9 −8.6 −7.8 −7.9 −8.1
2X5O −8.4 −8.6 −8.7 −8.4 −7.9 −6.9 −7.0 −8.9 −8.2 −7.1 −6.7 −7.7
2ZDQ −8.8 −7.6 −7.1 −7.1 −7.2 −9.6 −6.6 −7.3 −7.3 −6.5 −6.7 −6.1
3UDI −7.2 −8.0 −8.0 −8.9 −9.1 −8.1 −7.5 −8.9 −8.6 −7.5 −7.4 −7.8
Inhibition of protein synthesis 1HNJ −6.5 −7.6 −7.7 −6.8 −7.4 −8.2 −7.9 −6.9 −7.3 −7.5 −7.4 −6.3
4WYC −7.2 −9.5 −9.5 −9.1 −9.3 −9.9 −9.1 −9.2 −9.6 −8.9 −9.1 −8.2
Inhibition of nucleic acid 
synthesis
1KZN −8.7 −7.4 −6.8 −7.3 −8.1 −8.0 −7.6 −7.6 −7.8 −7.4 −7.4 −6.7
3TTZ −7.8 −7.1 −7.7 −7.2 −8.1 −7.5 −7.4 −6.8 −7.1 −7.6 −7.3 −6.8
Antimetabolites 2VEG −7.1 −7.6 −7.7 −6.9 −7.9 −7.6 −7.4 −7.1 −7.5 −7.0 −7.3 −7.1
3SRW −8.9 −6.8 −6.8 −6.6 −7.4 −9.1 −9.0 −7.1 −7.2 −9.0 −8.7 −6.0
3TYE −9.9 −7.9 −8.1 −7.8 −7.9 −7.9 −7.7 −7.8 −7.7 −7.5 −7.5 −6.8
Bold numbers indicate ligands with higher affinity than cocrystal ligands. PDB: Protein data bank
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Fig. 2: Comparison of cocrystal ligand (magenta) of 4WYC with 
berberine (peach) position
Fig. 3: Comparison of cocrystal ligand (magenta) of 2ZDQ with 
berberine (peach) position
